Iceutica Operations Drug Patent Portfolio
Iceutica Operations owns 1 orange book drug protected by 3 US patents Given below is the list of Iceutica Operations's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649318 | Formulation of meloxicam | 31 Mar, 2035 | Active |
| US9808468 | Formulation of meloxicam | 31 Mar, 2035 | Active |
| US9526734 | Formulation of meloxicam | 31 Mar, 2033 | Active |
Latest Legal Activities on Iceutica Operations's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Iceutica Operations.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 07 May, 2021 | US9808468 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 16 Nov, 2020 | US9649318 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 16 Oct, 2020 | US9649318 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 29 Jun, 2020 | US9526734 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 22 May, 2020 | US9526734 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Nov, 2017 | US9808468 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Nov, 2017 | US9808468 |
|
Email Notification
Critical
| 19 Oct, 2017 | US9808468 |
|
Issue Notification Mailed
Critical
| 18 Oct, 2017 | US9808468 |
|
Application Is Considered Ready for Issue
Critical
| 29 Sep, 2017 | US9808468 |
| Dispatch to FDC | 29 Sep, 2017 | US9808468 |
|
Issue Fee Payment Received
Critical
| 27 Sep, 2017 | US9808468 |
| Response to Reasons for Allowance | 27 Sep, 2017 | US9808468 |
|
Issue Fee Payment Verified
Critical
| 27 Sep, 2017 | US9808468 |
|
Email Notification
Critical
| 01 Sep, 2017 | US9808468 |
Iceutica Operations's Family Patents
Iceutica Operations Drug List
Given below is the complete list of Iceutica Operations's drugs and the patents protecting them.
1. Vivlodex
Vivlodex is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649318 | Formulation of meloxicam |
31 Mar, 2035
(9 years from now)
| Active |
| US9808468 | Formulation of meloxicam |
31 Mar, 2035
(9 years from now)
| Active |
| US9526734 | Formulation of meloxicam |
31 Mar, 2033
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vivlodex's drug page